ArticleJournal for immunotherapy of cancer2021

Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2

Yaya Chu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.